{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T12:40:18Z","timestamp":1789735218916,"version":"4.0.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008191","name":"Wings for Life Privatstiftung f\u00fcr R\u00fcckenmarksforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000245","name":"Michael Smith Foundation for Health Research","doi-asserted-by":"publisher","award":["RT-2023-3173"],"award-info":[{"award-number":["RT-2023-3173"]}],"id":[{"id":"10.13039\/501100000245","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","award":["P500PB_214416"],"award-info":[{"award-number":["P500PB_214416"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021409","name":"University of British Columbia International Collaboration on Repair Discoveries","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001708","name":"International Foundation For Research In Paraplegia","doi-asserted-by":"publisher","award":["P 198 F"],"award-info":[{"award-number":["P 198 F"]}],"id":[{"id":"10.13039\/501100001708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.ebiom.2024.105381","type":"journal-article","created":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T09:33:46Z","timestamp":1728380026000},"page":"105381","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"special_numbering":"C","title":["Next-gen spinal cord injury clinical trials: lessons learned and opportunities for future success"],"prefix":"10.1016","volume":"109","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7568-0133","authenticated-orcid":false,"given":"Paulina S.","family":"Scheuren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L.K.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2024.105381_bib1","doi-asserted-by":"crossref","first-page":"17018","DOI":"10.1038\/nrdp.2017.18","article-title":"Traumatic spinal cord injury","volume":"3","author":"Ahuja","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ebiom.2024.105381_bib2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1682\/JRRD.2004.08.0100","article-title":"Quality of life of individuals with spinal cord injury: a review of conceptualization, measurement, and research findings","volume":"42","author":"Dijkers","year":"2005","journal-title":"J\u00a0Rehabil Res Dev"},{"key":"10.1016\/j.ebiom.2024.105381_bib3","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3171\/2012.6.AOSPINE1252","article-title":"Quality of life in persons with spinal cord injury: comparisons with other populations","volume":"17","author":"Boakye","year":"2012","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.ebiom.2024.105381_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1038\/sj.sc.3100571","article-title":"Quality of life after spinal cord injury: a meta analysis of the effects of disablement components","volume":"35","author":"Dijkers","year":"1997","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib5","doi-asserted-by":"crossref","first-page":"113","DOI":"10.24095\/hpcdp.33.3.01","article-title":"The economic burden of traumatic spinal cord injury in Canada","volume":"33","author":"Krueger","year":"2013","journal-title":"Chronic Dis Inj Can"},{"key":"10.1016\/j.ebiom.2024.105381_bib6","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1177\/21925682211031190","article-title":"Direct cost of illness for spinal cord injury: a systematic review","volume":"12","author":"Malekzadeh","year":"2022","journal-title":"Global Spine J"},{"key":"10.1016\/j.ebiom.2024.105381_bib7","first-page":"9","article-title":"Economic impact of traumatic spinal cord injuries in the United States","volume":"6","author":"Merritt","year":"2019","journal-title":"Neuroimmunol Neuroinflammation"},{"key":"10.1016\/j.ebiom.2024.105381_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1179\/1079026813Z.000000000249","article-title":"Spinal cord injury facts and figures at a glance","volume":"37","author":"No authors","year":"2014","journal-title":"J\u00a0Spinal Cord Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib9","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1089\/neu.2018.5935","article-title":"A\u00a0review of clinical trials in spinal cord injury including biomarkers","volume":"35","author":"Badhiwala","year":"2018","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1007\/s13311-018-0632-5","article-title":"Clinical trials in traumatic spinal cord injury","volume":"15","author":"Donovan","year":"2018","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebiom.2024.105381_bib11","doi-asserted-by":"crossref","first-page":"E14","DOI":"10.3171\/FOC.2008.25.11.E14","article-title":"Protection and repair of the injured spinal cord: a review of completed, ongoing, and planned clinical trials for acute spinal cord injury","volume":"25","author":"Hawryluk","year":"2008","journal-title":"Neurosurg Focus"},{"key":"10.1016\/j.ebiom.2024.105381_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4055\/cios.2017.9.1.1","article-title":"Spinal cord injury and related clinical trials","volume":"9","author":"Kim","year":"2017","journal-title":"Clin Orthop Surg"},{"key":"10.1016\/j.ebiom.2024.105381_bib13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/sc.2012.137","article-title":"Clinical trials in spinal cord injury: lessons learned on the path to translation. The 2011 international spinal cord society sir ludwig guttmann lecture","volume":"51","author":"Lammertse","year":"2013","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib14","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.STR.32.6.1349","article-title":"Trends in acute ischemic stroke trials through the 20th century","volume":"32","author":"Kidwell","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.ebiom.2024.105381_bib15","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1056\/NEJM199005173222001","article-title":"A\u00a0randomized, controlled trial of methylprednisolone or naloxone in the treatment of acute spinal-cord injury","volume":"322","author":"Bracken","year":"1990","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib16","first-page":"23","article-title":"Methylprednisolone or naloxone treatment after acute spinal cord injury: 1-year follow-up data","volume":"76","author":"Bracken","year":"1992","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ebiom.2024.105381_bib17","first-page":"699","article-title":"Methylprednisolone or tirilazad mesylate administration after acute spinal cord injury: 1-year follow up","volume":"89","author":"Bracken","year":"1998","journal-title":"J\u00a0Neurosurg"},{"key":"10.1016\/j.ebiom.2024.105381_bib18","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1001\/jama.1997.03540440031029","volume":"277","author":"Bracken","year":"1997","journal-title":"JAMA"},{"issue":"Suppl 1","key":"10.1016\/j.ebiom.2024.105381_bib19","first-page":"49","article-title":"GM-1 ganglioside and motor recovery following human spinal cord injury","volume":"11","author":"Geisler","year":"1993","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib20","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1056\/NEJM199106273242601","article-title":"Recovery of motor function after spinal-cord injury \u2014 a randomized, placebo-controlled trial with GM-1 ganglioside","volume":"324","author":"Geisler","year":"1991","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib21","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/00007632-200112151-00015","article-title":"The Sygen\u00ae multicenter acute spinal cord injury study","volume":"26","author":"Geisler","year":"2001","journal-title":"Spine"},{"key":"10.1016\/j.ebiom.2024.105381_bib22","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1038\/sj.sc.3101947","article-title":"Phase 2 trial of sustained-release fampridine in chronic spinal cord injury","volume":"45","author":"Cardenas","year":"2007","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib23","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/sc.2013.137","article-title":"Two phase 3, multicenter, randomized, placebo-controlled clinical trials of fampridine-SR for treatment of spasticity in chronic spinal cord injury","volume":"52","author":"Cardenas","year":"2014","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib24","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1038\/sc.2010.29","article-title":"A\u00a0phase 2 autologous cellular therapy trial in patients with acute, complete spinal cord injury: pragmatics, recruitment, and demographics","volume":"48","author":"Jones","year":"2010","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib25","doi-asserted-by":"crossref","first-page":"173","DOI":"10.3171\/spi.2005.3.3.0173","article-title":"Clinical experience using incubated autologous macrophages as a treatment for complete spinal cord injury: phase I study results","volume":"3","author":"Knoller","year":"2005","journal-title":"J\u00a0Neurosurg Spine"},{"key":"10.1016\/j.ebiom.2024.105381_bib26","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamaneurol.2017.0318","article-title":"Challenges to translation and the hippocratic oath by premature termination of spinal cord stem cell-based trials","volume":"74","author":"Curt","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib27","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S1474-4422(23)00215-6","article-title":"Soluble Nogo-Receptor-Fc decoy (AXER-204) in patients with chronic cervical spinal cord injury in the USA: a first-in-human and randomised clinical trial","volume":"22","author":"Maynard","year":"2023","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib28","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/s41393-020-00547-8","article-title":"Adaptive trial designs for spinal cord injury clinical trials directed to the central nervous system","volume":"58","author":"Mulcahey","year":"2020","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib29","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/sc.2015.95","article-title":"Rationale, design and critical end points for the Riluzole in Acute Spinal Cord Injury Study (RISCIS): a randomized, double-blinded, placebo-controlled parallel multi-center trial","volume":"54","author":"Fehlings","year":"2016","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib30","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1089\/neu.2017.5434","article-title":"Rho inhibitor VX-210 in acute traumatic subaxial cervical spinal cord injury: design of the SPinal cord injury rho INhibition InvestiGation (SPRING) clinical trial","volume":"35","author":"Fehlings","year":"2018","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib31","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1089\/neu.2020.7096","article-title":"A\u00a0randomized controlled trial of local delivery of a rho inhibitor (VX-210) in patients with acute traumatic cervical spinal cord injury","volume":"38","author":"Fehlings","year":"2021","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib32","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1089\/neu.2023.0163","article-title":"Safety and efficacy of Riluzole in acute spinal cord injury (RISCIS): a multi-center, randomized, placebo-controlled, double-blinded trial","volume":"40","author":"Fehlings","year":"2023","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib33","doi-asserted-by":"crossref","first-page":"436","DOI":"10.5465\/amj.2013.1109","article-title":"Fail often, fail big, and fail fast? Learning from small failures and R&D performance in the pharmaceutical industry","volume":"59","author":"Khanna","year":"2016","journal-title":"Acad Manag J"},{"key":"10.1016\/j.ebiom.2024.105381_bib34","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1089\/neu.2016.4879","article-title":"A\u00a0targeted proteomics analysis of cerebrospinal fluid after acute human spinal cord injury","volume":"34","author":"Streijger","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib35","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1089\/neu.2009.1080","article-title":"Cerebrospinal fluid inflammatory cytokines and biomarkers of injury severity in acute human spinal cord injury","volume":"27","author":"Kwon","year":"2010","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/neu.2016.4435","article-title":"Cerebrospinal fluid biomarkers to stratify injury severity and predict outcome in human traumatic spinal cord injury","volume":"34","author":"Kwon","year":"2017","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib37","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1016\/j.apmr.2016.03.017","article-title":"Changing demographics and injury profile of new traumatic spinal cord injuries in the United States, 1972\u20132014","volume":"97","author":"Chen","year":"2016","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/j.ebiom.2024.105381_bib38","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1186\/s12916-022-02395-0","article-title":"International surveillance study in acute spinal cord injury confirms viability of multinational clinical trials","volume":"20","author":"Bourguignon","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib39","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1089\/neu.2006.23.1621","article-title":"Fighting for each segment: estimating the clinical value of cervical and thoracic segments in SCI","volume":"23","author":"Hedel van","year":"2006","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/neu.2010.1504","article-title":"The graded redefined assessment of strength sensibility and prehension: reliability and validity","volume":"29","author":"Kalsi-Ryan","year":"2012","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.46292\/sci2702-1","article-title":"International standards for neurological classification of spinal cord injury","volume":"27","author":"Rupp","year":"2021","journal-title":"Top Spinal Cord Inj Rehabil"},{"key":"10.1016\/j.ebiom.2024.105381_bib42","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3389\/fneur.2018.00011","article-title":"A critical examination of subgroup analyses: the national acute spinal cord injury studies and beyond","volume":"9","author":"Hextrum","year":"2018","journal-title":"Front Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib43","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1089\/neu.2020.7407","article-title":"Unbiased recursive partitioning enables robust and reliable outcome prediction in acute spinal cord injury","volume":"39","author":"Buri","year":"2022","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib44","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1177\/1545968315570322","article-title":"Toward inclusive trial protocols in heterogeneous neurological disorders: prediction-based stratification of participants with incomplete cervical spinal cord injury","volume":"29","author":"Tanadini","year":"2015","journal-title":"Neurorehabilitation Neural Repair"},{"key":"10.1016\/j.ebiom.2024.105381_bib45","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1177\/1545968313520413","article-title":"Identifying homogeneous subgroups in neurological disorders: unbiased recursive partitioning in cervical complete spinal cord injury","volume":"28","author":"Tanadini","year":"2014","journal-title":"Neurorehabilitation Neural Repair"},{"key":"10.1016\/j.ebiom.2024.105381_bib46","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41591-021-01663-5","article-title":"Activity-dependent spinal cord neuromodulation rapidly restores trunk and leg motor functions after complete paralysis","volume":"28","author":"Rowald","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib47","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41586-023-06094-5","article-title":"Walking naturally after spinal cord injury using a brain\u2013spine interface","volume":"618","author":"Lorach","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.ebiom.2024.105381_bib48","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1109\/TNSRE.2018.2834339","article-title":"Transcutaneous electrical spinal stimulation promotes long-term recovery of upper extremity function in chronic tetraplegia","volume":"26","author":"Inanici","year":"2018","journal-title":"IEEE Trans Neural Syst Rehabil Eng"},{"key":"10.1016\/j.ebiom.2024.105381_bib49","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1038\/s41591-024-02940-9","article-title":"Non-invasive spinal cord electrical stimulation for arm and hand function in chronic tetraplegia: a safety and efficacy trial","volume":"30","author":"Moritz","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib50","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1089\/neu.2020.7590","article-title":"Phase 1 safety trial of autologous human Schwann cell transplantation in chronic spinal cord injury","volume":"39","author":"Gant","year":"2022","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib51","doi-asserted-by":"crossref","first-page":"12308","DOI":"10.1073\/pnas.91.25.12308","article-title":"Key role for pregnenolone in combination therapy that promotes recovery after spinal cord injury","volume":"91","author":"Guth","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.ebiom.2024.105381_bib52","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1038\/nm1436","article-title":"Nogo-A-specific antibody treatment enhances sprouting and functional recovery after cervical lesion in adult primates","volume":"12","author":"Freund","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib53","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1111\/j.1460-9568.2009.06642.x","article-title":"Anti-Nogo-A antibody treatment promotes recovery of manual dexterity after unilateral cervical lesion in adult primates - Re-examination and extension of behavioral data","volume":"29","author":"Freund","year":"2009","journal-title":"Eur J Neurosci"},{"key":"10.1016\/j.ebiom.2024.105381_bib54","doi-asserted-by":"crossref","first-page":"3665","DOI":"10.1523\/JNEUROSCI.21-10-03665.2001","article-title":"Locomotor recovery in spinal cord-injured rats treated with an antibody neutralizing the myelin-associated neurite growth inhibitor nogo-A","volume":"21","author":"Merkler","year":"2001","journal-title":"J\u00a0Neurosci"},{"key":"10.1016\/j.ebiom.2024.105381_bib55","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ana.22527","article-title":"Recovery from chronic spinal cord contusion after nogo receptor intervention","volume":"70","author":"Wang","year":"2011","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib56","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1002\/ana.20953","article-title":"Delayed nogo receptor therapy improves recovery from spinal cord contusion","volume":"60","author":"Wang","year":"2006","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib57","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1089\/neu.2014.3355","article-title":"Human NgR-Fc decoy protein via lumbar intrathecal bolus administration enhances recovery from rat spinal cord contusion","volume":"31","author":"Wang","year":"2014","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib58","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0140-6736(13)61912-1","article-title":"Chronic cerebrospinal venous insufficiency in multiple sclerosis: the final curtain","volume":"383","author":"Paul","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2024.105381_bib59","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1177\/1545968315624777","article-title":"Effects of pain and pain management on motor recovery of spinal cord-injured patients: a longitudinal study","volume":"30","author":"Cragg","year":"2016","journal-title":"Neurorehabilitation Neural Repair"},{"key":"10.1016\/j.ebiom.2024.105381_bib60","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/j.celrep.2017.01.048","article-title":"Early administration of gabapentinoids improves motor recovery after human spinal cord injury","volume":"18","author":"Warner","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2024.105381_bib61","doi-asserted-by":"crossref","first-page":"E3412","DOI":"10.1212\/WNL.0000000000010950","article-title":"Association of timing of gabapentinoid use with motor recovery after spinal cord injury","volume":"95","author":"Warner","year":"2020","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105381_bib62","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1007\/s13311-019-00713-8","article-title":"A\u00a0longitudinal study of the neurologic safety of acute baclofen use after spinal cord injury","volume":"16","author":"Cragg","year":"2019","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.ebiom.2024.105381_bib63","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.neuron.2016.09.026","article-title":"The calcium channel subunit Alpha2delta2 suppresses axon regeneration in the adult CNS","volume":"92","author":"Tedeschi","year":"2016","journal-title":"Neuron"},{"key":"10.1016\/j.ebiom.2024.105381_bib64","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1172\/JCI130391","article-title":"Gabapentinoid treatment promotes corticospinal plasticity and regeneration following murine spinal cord injury","volume":"130","author":"Sun","year":"2020","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.ebiom.2024.105381_bib65","series-title":"Feasibility of gabapentin as an intervention for neurorecovery after an acute spinal cord injury: protocol","author":"Shortland","year":"2022"},{"key":"10.1016\/j.ebiom.2024.105381_bib66","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1089\/neu.2022.0403","article-title":"North American clinical trials network for spinal cord injury registry: methodology and analysis","volume":"40","author":"Toups","year":"2023","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12916-018-1017-7","article-title":"Adaptive designs in clinical trials: why use them, and how to run and report them","volume":"16","author":"Pallmann","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/j.ebiom.2024.105381_bib68","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/ana.26714","article-title":"Design and statistical innovations in a platform trial for amyotrophic lateral sclerosis","volume":"94","author":"Quintana","year":"2023","journal-title":"Ann Neurol"},{"key":"10.1016\/j.ebiom.2024.105381_bib69","doi-asserted-by":"crossref","first-page":"E1221","DOI":"10.1212\/WNL.0000000000206744","article-title":"Association of CSF and serum neurofilament light and glial fibrillary acidic protein, injury severity, and outcome in spinal cord injury","volume":"100","author":"Stukas","year":"2023","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105381_bib70","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","article-title":"Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome","volume":"86","author":"Kuhle","year":"2015","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2024.105381_bib71","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41393-019-0309-x","article-title":"Guidelines for the conduct of clinical trials in spinal cord injury: neuroimaging biomarkers","volume":"57","author":"Seif","year":"2019","journal-title":"Spinal Cord"},{"key":"10.1016\/j.ebiom.2024.105381_bib72","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1177\/21925682231183969","article-title":"A\u00a0clinical practice guideline on the timing of surgical decompression and hemodynamic management of acute spinal cord injury and the prevention, diagnosis, and management of intraoperative spinal cord injury: introduction, rationale, and scope","volume":"14","author":"Tetreault","year":"2024","journal-title":"Global Spine J"},{"key":"10.1016\/j.ebiom.2024.105381_bib73","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13023-020-1332-x","article-title":"A roadmap to using historical controls in clinical trials - by drug information association adaptive design scientific working group (DIA-ADSWG)","volume":"15","author":"Ghadessi","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.ebiom.2024.105381_bib74","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1212\/WNL.0000000000000951","article-title":"The PRO-ACT database","volume":"83","author":"Atassi","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.ebiom.2024.105381_bib75","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1089\/neu.2019.6674","article-title":"FAIR SCI ahead: the evolution of the open data commons for pre-clinical spinal cord injury research","volume":"37","author":"Fouad","year":"2020","journal-title":"J\u00a0Neurotrauma"},{"key":"10.1016\/j.ebiom.2024.105381_bib76","first-page":"4211","article-title":"Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs","volume":"109","author":"Chopra","year":"2023","journal-title":"Int J Surg"},{"key":"10.1016\/j.ebiom.2024.105381_bib77","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.15643","article-title":"Riluzole for degenerative cervical Myelopathy - a secondary analysis of the CSM-PROTECT trial","volume":"7","author":"Fehlings","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396424004171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:38:27Z","timestamp":1732045107000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396424004171"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":77,"alternative-id":["S2352396424004171"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105381","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Next-gen spinal cord injury clinical trials: lessons learned and opportunities for future success","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2024.105381","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105381"}}